Untitled

Loading Events

« All Webinars

“To Cool or Not to Cool? The latest on targeted temperature management after cardiac arrest”

Saxe Communications & Stryker* present…“To Cool or Not to Cool? The latest on targeted temperature management after cardiac arrest”

Moderate therapeutic hypothermia is currently recommended to improve neurologic outcomes in adults with persistent coma after resuscitated out-of-hospital cardiac arrest. Recently published studies have re-examined this practice to determine the most effective targeted temperature. Questions that are addressed include whether it should it be 33° C or 36° C or just avoid fever? You will learn the most up to date information from two experts with direct experience with this therapy for over two decades. They will share insights from their published studies as well as the results of the HYPERION and TTM2 trials.

Learning Objectives  |  Upon completion of this activity, the participant will be able to:

  1. Discuss the findings of recent published studies including the TTM-2 and HYPERION trials
  2. Discuss the concept of high quality TTM and tailoring therapy to severity of post-arrest injury

Presenters:

Benjamin Abella, M.D., MPHIL  |  Director, Center for Resuscitation Science  |  University of Pennsylvania

Nicole Kupchik, MN, RN, CCNS, CCRN, PCCN, CMC  |  CEO and Independent Clinical Nurse Specialist  |  Nicole Kupchik Consulting, Inc.

Continuing Education for Nurses & Respiratory Therapists

This program has been approved for 1.0 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care. Provider approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032.

Support for this educational activity provided by Stryker.*

Questions should be directed to Saxe Communications: webinair@saxecommunications.com

* NOTE: This is an industry resource and/or supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.